Fingerprint
Dive into the research topics of 'Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myeloma
Ruben Niesvizky, Scott Ely, Tomer Mark, Sangeeta Aggarwal, Janice L. Gabrilove, John J. Wright, Selina Chen-Kiang, Joseph A. Sparano
Research output: Contribution to journal › Article › peer-review
119
Scopus
citations